Patents by Inventor Juliet Spencer

Juliet Spencer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG-3 RECEPTOR
    Publication number: 20070032459
    Abstract: In one aspect, the present invention provides a method of modulating an Edg-3 receptor mediated biological activity in a cell. A cell expressing the Edg-3 receptor is contacted with a modulator of the Edg-3 receptor sufficient to modulate the Edg-3 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating an Edg-3 receptor mediated biological activity in a subject. A therapeutically effective amount of a modulator of the Edg-3 receptor is administered to the subject. In yet another aspect, compounds and composition useful for modulation of the Edg-3 receptor are presented.
    Type: Application
    Filed: March 14, 2003
    Publication date: February 8, 2007
    Inventors: David Solow-Cordero, Geetha Shankar, Juliet Spencer, Charles Gluchowski
  • Methods of treating conditions associated with an Edg-7 receptor
    Publication number: 20050261298
    Abstract: In one aspect, the present invention provides a method for modulating an Edg-7 receptor mediated biological activity in a cell. A cell expressing the Edg-7 receptor is contacted with a modulator of the Edg-7 receptor which is capable of modulating an Edg-7 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating an Edg-7 receptor mediated biological activity in a subject. A therapeutically effective amount of a modulator of the Edg-7 receptor is administered to the subject.
    Type: Application
    Filed: March 14, 2003
    Publication date: November 24, 2005
    Inventors: David Solow-Cordero, Geetha Shankar, Juliet Spencer, Charles Gluchowski
  • Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
    Publication number: 20050191274
    Abstract: The present invention is provides pharmaceutical compositions and prophylactic and therapeutic methods of treatment for immune disorders using rhesus or human CMV IL-10. The invention is useful for inhibiting lymphocyte proliferation and underlying cellular events both in vitro and in vivo.
    Type: Application
    Filed: February 10, 2005
    Publication date: September 1, 2005
    Applicant: ChemoCentryx, Inc.
    Inventors: Thomas Schall, Mark Penfold, Juliet Spencer
  • Methods of treating conditions associated with an EDG-4 receptor
    Publication number: 20050113283
    Abstract: The present invention provides a method of modulating an Edg-4 receptor mediated biological activity in a cell. A cell expressing the Edg-4 receptor is contacted with a modulator of an Edg-4 receptor sufficient to modulate the Edg-4 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating an Edg-4 receptor mediated biological activity in a subject. A therapeutically effective amount of a modulator of the Edg-4 receptor is administered to the subject.
    Type: Application
    Filed: March 14, 2003
    Publication date: May 26, 2005
    Inventors: David Solow-Cordero, Geetha Shankar, Juliet Spencer, Charles Gluchowski
  • Methods of treating conditions associated with an EDG-2 receptor
    Publication number: 20050101518
    Abstract: In one aspect, the present invention provides a method for modulating an Edg-2 receptor mediated biological activity in a cell. A cell expressing the Edg-2 receptor is contacted with an modulator of the Edg-2 receptor, which modulates the Edg-2 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating Edg-2 receptor mediated biological activity in a subject. A therapeutically effective amount of an modulator of the Edg-2 receptor is administered to the subject.
    Type: Application
    Filed: March 14, 2003
    Publication date: May 12, 2005
    Inventors: David Solow-Cordero, Geetha Shankar, Juliet Spencer, Charles Gluchowski
  • Methods of treating conditions associated with an Edg-2 receptor
    Publication number: 20050065194
    Abstract: In one aspect, the present invention provides a method for modulating an Edg-2 receptor mediated biological activity in a cell. A cell expressing the Edg-2 receptor is contacted with an modulator of the Edg-2 receptor, which modulates the Edg-2 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating Edg-2 receptor mediated biological activity in a subject. A therapeutically effective amount of an modulator of the Edg-2 receptor is administered to the subject.
    Type: Application
    Filed: January 16, 2004
    Publication date: March 24, 2005
    Inventors: Geetha Shankar, David Solow-Cordero, Juliet Spencer, Charles Gluchowski
  • Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
    Publication number: 20020197234
    Abstract: The present invention is provides pharmaceutical compositions and prophylactic and therapeutic methods of treatment for immune disorders using rhesus or human CMV IL-10. The invention is useful for inhibiting lymphocyte proliferation and underlying cellular events both in vitro and in vivo.
    Type: Application
    Filed: July 30, 2001
    Publication date: December 26, 2002
    Applicant: ChemoCentryx, Inc.
    Inventors: Thomas J. Schall, Mark Penfold, Juliet Spencer